IperionX Plunges 37% as 'Strong Buy' Rating Clashes With Bearish Signals

Market Snapshot

IperionX (IPX.O) is currently in a bearish technical phase with a steep price drop of -36.97% recently, backed by weak indicators and an internal diagnostic score of just 3.79. Investors are advised to avoid this stock unless there’s a clear reversal in the coming weeks.

News Highlights

Recent developments in the mining and metals sector are mixed. Greenland Resources signed a MOU with German Dillinger for molybdenum supply, which could benefit the broader market. Meanwhile, geopolitical tensions from the 2026 Iran war are increasing supply chain risks. On the exploration front, Usha Resources completed an extended induced polarization survey, potentially signaling further mineral interest. These events could indirectly affect IperionX’s market perception but do not provide immediate support for the stock.

Analyst Views & Fundamentals

In the past 20 days, only one analyst, Lucas Pipes of B. Riley Securities, has issued a rating for IPX.O—a "Strong Buy." However, this recommendation is at odds with the stock’s actual performance. The analyst’s historical win rate is 0.00%, and average returns are -19.37%, raising questions about the reliability of the "Strong Buy" label. The simple average rating is 5.00, but the weighted score is 0.00 due to poor historical performance, showing significant divergence between ratings and reality. These inconsistencies suggest analysts may be overly optimistic, while the stock continues to fall.

On the fundamental side, IperionX shows troubling metrics. The company’s annualized net profit margin on total assets is -44.06%, indicating severe underperformance. Its ROE (diluted) stands at -38.24%, another red flag. The current assets turnover ratio is 2.39, which is relatively high, but it's not enough to offset the losses elsewhere. These factors contribute to an overall internal diagnostic score of 0.61, signaling poor fundamental health.

Money-Flow Trends

Despite the stock’s poor technical and fundamental indicators, money flow patterns show some interesting activity. The inflow ratio for small, medium, and large investors is close to 50%, suggesting moderate interest across retail and institutional levels. However, the overall trend remains negative, with the block trend also leaning bearish. The fund flow score is 7.66, an internal diagnostic score (0-10), which indicates "good" relative strength in terms of inflow ratios, but this does not override the strong bearish signals from other areas.

Key Technical Signals

Technically, IperionX has struggled in the last five days. The MACD Death Cross and multiple appearances of a Long Lower Shadow are clear bearish indicators. The MACD Death Cross has an internal diagnostic score of 2.67 (out of 10), while the Long Lower Shadow scores a weak 2.15. The Long Upper Shadow, though appearing twice, only scores 6.54, and is rated as "Neutral rise." The recent chart patterns, especially the repeated Long Lower Shadow, suggest weak recovery attempts and a lack of buyer confidence. The technical analysis summary emphasizes that bearish signals dominate, with only one neutral indicator and no bullish ones, reinforcing the view to avoid the stock.

Conclusion

Given the poor technical signals, weak fundamentals, and questionable analyst ratings, IperionX is not a favorable investment at this time. Investors are advised to avoid new positions and consider waiting for a more defined trend reversal or a clearer sign of strength. For now, the market appears to be pushing the stock downward, and the internal diagnostic scores support that view.